Biotech Briefing: Boston Scientific Acquires Vertiflex for $465 Million Plus Milestones

Vertiflex acquiredReports + Research Boston Scientific Acquires Vertiflex for $465 Million Plus Milestones Carlsbad-based Vertiflex makes a minimally invasive vertebrae spacer for treating lumbar stenosis, a narrowing of the spinal canal. Affecting an estimated six million people, the degenerative condition compresses nerves, leading to lower back and leg pain and numbness and trouble walking.¬†According to FierceBiotech, …

The post Biotech Briefing: Boston Scientific Acquires Vertiflex for $465 Million Plus Milestones appeared first on Hatch.

Click to view original post